[
  {
    "question": "A 26-year-old female with AIDS (CD4 count: 47) presents to the emergency department in severe pain. She states that over the past week she has been fatigued and has had a progressively worse headache and fever. These symptoms have failed to remit leading her to seek care in the ED. A lumbar puncture is performed which demonstrates an opening pressure of 285 mm H2O, increased lymphocytes, elevated protein, and decreased glucose. The emergency physician subsequently initiates treatment with IV amphotericin B and PO flucytosine. What additional treatment in the acute setting may be warranted in this patient?",
    "answer": "This patient likely has cryptococcal meningitis, a common opportunistic infection in AIDS patients with low CD4 counts. Given the elevated intracranial pressure, this patient may benefit from a lumbar puncture to reduce intracranial pressure and prevent further neurological decline.",
    "true_answer": "In the acute setting, serial lumbar punctures may be warranted for this patient to manage elevated intracranial pressure."
  },
  {
    "question": "You are reviewing raw data from a research study performed at your medical center examining the effectiveness of a novel AIDS screening examination. The study enrolled 250 patients with confirmed AIDS, and 240 of these patients demonstrated a positive screening examination. The control arm of the study enrolled 250 patients who do not have AIDS, and only 5 of these patients tested positive on the novel screening examination. What is the NPV of this novel test?",
    "answer": "## Calculating the Negative Predictive Value (NPV) of a Test\n\nThe Negative Predictive Value (NPV) is a measure of the probability that a patient with a negative test result truly does not have the disease. To calculate the NPV, we need to understand the following:\n\n- **Sensitivity (True Positive Rate)**: The proportion of actual positives that are correctly identified by the test.\n- **Specificity (True Negative Rate)**: The proportion of actual negatives that are correctly identified by the test.\n- **Prevalence**: The proportion of the population that has the disease.\n\n### Given Data:\n- Total patients with confirmed AIDS: 250\n- Patients with confirmed AIDS and positive test result: 240\n- Total patients without AIDS: 250\n- Patients without AIDS and positive test result: 5\n\n### Calculating Sensitivity and Specificity:\n- **Sensitivity**: 240/250 = 0.96 (96%)\n- **Specificity**: 245/250 = 0.98 (98%)\n\n### Calculating Prevalence:\n- **Prevalence**: 250/500 = 0.5 (50%)\n\n### Calculating Negative Predictive Value (NPV):\n- **NPV**: (Specificity x (1 - Prevalence)) / ((1 - Sensitivity) x Prevalence + Specificity x (1 - Prevalence))\n- **NPV**: (0.98 x (1 - 0.5)) / ((1 - 0.96) x 0.5 + 0.98 x (1 - 0.5))\n- **NPV**: (0.98 x 0.5) / (0.04 x 0.5 + 0.98 x 0.5)\n- **NPV**: 0.49 / (0.02 + 0.49)\n- **NPV**: 0.49 / 0.51\n- **NPV**: 0.96\n\n### Answer:\nThe NPV of this novel test is 0.96.",
    "true_answer": "The NPV of this test is calculated as the proportion of true negatives among all negative results, 245 / (245 + 10) = 0.96."
  },
  {
    "question": "A 46-year-old Caucasian male with past medical history of HIV (CD4: 77/mm^3), hypertension, hyperlipidemia, and osteoarthritis presents to the emergency department with sudden weakness of his right hand. He reports that the weakness has gradually been getting worse and that this morning he dropped his cup of coffee. He has never had anything like this happen to him before, although he was hospitalized last year for pneumonia. He reports inconsistent adherence to his home medications, which include raltegravir, tenofovir, emtricitabine, TMP-SMX, hydrochlorothiazide, pravastatin, and occasional ibuprofen. His father died of a myocardial infarction at the age of 60, and his mother suffered a stroke at the age of 72. The patient's temperature is 102.6\u00b0F (39.2\u00b0C), blood pressure is 156/92 mmHg, pulse is 88/min, and respirations are 18/min. On neurological exam, he has 3/5 strength in the distal muscles of the right extremity with preserved sensation. His neurological exam is normal in all other extremities. What is the next best step in management for this patient?",
    "answer": "This patient's presentation of sudden weakness in one extremity, with a history of HIV infection and a low CD4 count, is concerning for a central nervous system (CNS) infection such as toxoplasmosis or cryptococcal meningitis. However, his focal neurological signs and fever may also suggest a CNS abscess or another condition such as a cerebrovascular accident (CVA). Given the patient's significant immunocompromised state and neurological symptoms, he should undergo imaging, ideally an MRI of the brain with contrast, to evaluate for these possibilities. While a CT scan is more readily available and often used in the acute setting, MRI is more sensitive for detecting the lesions associated with toxoplasmosis and other CNS infections.",
    "true_answer": "The next best step in management is to perform a head CT (Computed Tomography) scan to investigate the cause of neurological symptoms."
  },
  {
    "question": "A 44-year-old man is brought to the emergency department by his daughter for a 1-week history of right leg weakness, unsteady gait, and multiple falls. During the past 6 months, he has become more forgetful and has sometimes lost his way along familiar routes. He has been having difficulties operating simple kitchen appliances such as the dishwasher and the coffee maker. He has recently become increasingly paranoid, agitated, and restless. He has HIV, hypertension, and type 2 diabetes mellitus. His last visit to a physician was more than 2 years ago, and he has been noncompliant with his medications. His temperature is 37.2 \u00b0C (99.0 \u00b0F), blood pressure is 152/68 mm Hg, pulse is 98/min, and respirations are 14/min. He is somnolent and slightly confused. He is oriented to person, but not place or time. There is mild lymphadenopathy in the cervical, axillary, and inguinal areas. Neurological examination shows right lower extremity weakness with normal tone and no other focal deficits. Laboratory studies show: Hemoglobin 9.2 g/dL, Leukocyte count 3600/mm3, Platelet count 140,000/mm3, CD4+ count 56/\u03bcL, HIV viral load > 100,000 copies/mL, Serum: Cryptococcal antigen negative, Toxoplasma gondii IgG positive. An MRI of the brain shows disseminated, nonenhancing white matter lesions with no mass effect. What is the most likely diagnosis?",
    "answer": "This patient's presentation of progressive neurological deficits, cognitive impairment, psychiatric symptoms, and HIV/AIDS with a low CD4+ count, along with the MRI findings of disseminated nonenhancing white matter lesions, is highly suggestive of Progressive Multifocal Leukoencephalopathy (PML). PML is a rare and often fatal demyelinating disease of the central nervous system caused by the JC virus, which targets oligodendrocytes. It typically occurs in immunocompromised individuals, such as those with advanced HIV/AIDS. Treatment for PML is primarily supportive and includes antiretroviral therapy to improve the immune status.",
    "true_answer": "The most likely diagnosis is progressive multifocal leukoencephalopathy."
  },
  {
    "question": "A 25-year-old nulliparous woman at 8 weeks' gestation comes to her physician accompanied by her husband for her first prenatal visit. She has no personal or family history of serious illness. Her vaccinations are up-to-date and she takes no medications. She has no history of recreational drug use and does not drink alcohol. Her vital signs are within normal limits. She is 167 cm (5 ft 6 in) tall and weighs 68 kg (150 lb); BMI is 24.3 kg/m2. She tested negative for HIV, Chlamydia trachomatis, and Neisseria gonorrhoeae 4 years ago. What following tests should be done at this visit?",
    "answer": "## Initial Prenatal Visit Tests for a 25-Year-Old Nulliparous Woman\n\n### Introduction:\nAt the initial prenatal visit, it is essential to assess the patient's overall health and perform necessary tests to ensure a healthy pregnancy. The tests should be tailored to the patient's age, gestational age, and medical history.\n\n### Recommended Tests:\n#### 1. **Complete Blood Count (CBC)**\n- Evaluates the patient's hematological status, including anemia and infection.\n- Essential for early detection and management of potential complications.\n\n#### 2. **Rh(D) Blood Type and Antibody Screen**\n- Determines the patient's blood type and Rh status.\n- Essential for identifying potential complications, such as hemolytic disease of the newborn.\n\n#### 3. **Blood Type and Antibody Screen**\n- Evaluates the patient's blood type and potential antibody presence.\n- Helps identify potential complications, such as hemolytic disease of the newborn.\n\n#### 4. **Rubella Titers**\n- Assesses the patient's immunity to rubella.\n- Essential for preventing congenital rubella syndrome.\n\n#### 5. **HIV**\n- Evaluates the patient's HIV status.\n- Essential for preventing mother-to-child transmission.\n\n#### 6. **HBsAg (Hepatitis B Surface Antigen)**\n- Assesses the patient's hepatitis B status.\n- Essential for preventing mother-to-child transmission.\n\n#### 7. **RPR (Rapid Plasma Reagin)**\n- Evaluates the patient's syphilis status.\n- Essential for preventing congenital syphilis.\n\n#### 8. **Pap Smear (If Not Done Within Past Year)**\n- Evaluates the patient's cervical health.\n- Essential for early detection and management of cervical abnormalities.\n\n#### 9. **Urinalysis**\n- Evaluates the patient's urinary tract health.\n- Essential for detecting potential complications, such as urinary tract infections.\n\n#### 10. **Cultures for Neisseria gonorrhoeae and Chlamydia trachomatis**\n- Evaluates the patient's genital tract health.\n- Essential for detecting potential sexually transmitted infections.\n\n#### 11. **Urine Culture if Urinalysis Shows Bacteriuria**\n- Evaluates the patient's urinary tract health.\n- Essential for detecting potential urinary tract infections.\n\n### Summary:\nThe initial prenatal visit is a critical opportunity to assess the patient's overall health and perform necessary tests to ensure a healthy pregnancy. The recommended tests should be tailored to the patient's age, gestational age, and medical history.",
    "true_answer": "Tests to conduct at this visit include ELISA for HIV, a rapid plasma reagin test, and serum HBsAg."
  },
  {
    "question": "A 33-year-old HIV-positive male is seen in clinic for follow-up care. When asked if he has been adhering to his HIV medications, the patient exclaims that he has been depressed, thus causing him to not take his medication for six months. His CD4+ count is now 33 cells/mm3. What medication(s) should he take in addition to his anti-retroviral therapy?",
    "answer": "This patient has a CD4+ count of less than 50 cells/mm3, which puts him at increased risk for Pneumocystis jirovecii pneumonia. Given his history, he should be started on Pneumocystis jirovecii prophylaxis with trimethoprim-sulfamethoxazole.",
    "true_answer": "In addition to his antiretroviral therapy, the patient should take azithromycin and trimethoprim-sulfamethoxazole to prevent opportunistic infections."
  },
  {
    "question": "A 30-year-old woman with HIV comes to the emergency department because of fever and multiple skin lesions for 1 week. She also has nausea, anorexia, and abdominal pain. The skin lesions are non-pruritic and painless. She has smoked one pack of cigarettes daily for 15 years and drinks 2 beers daily. She has been using intravenous crack cocaine for 6 years. She appears ill. Her temperature is 38\u00b0C (100.4\u00b0F), pulse is 105/min, blood pressure is 110/75 mm Hg. Her BMI is 19 kg/m2. Examination shows track marks on both cubital fossae. There are white patches on her palate that can be scraped off. There are several red papules measuring 1 to 2 cm on her face and trunk. Her CD4+T-lymphocyte count is 98/mm3 (N \u2265 500). Biopsy of a skin lesion shows vascular proliferation and small black bacteria on Warthin-Starry stain. What is the most appropriate pharmacotherapy?",
    "answer": "### Patient Presentation and Diagnosis\n\nA 30-year-old woman with HIV presents to the emergency department with the following symptoms:\n\n* Fever and multiple skin lesions for 1 week\n* Nausea, anorexia, and abdominal pain\n* Non-pruritic and painless skin lesions\n* History of smoking, alcohol consumption, and intravenous crack cocaine use\n* Ill appearance with a temperature of 38\u00b0C (100.4\u00b0F), pulse of 105/min, and blood pressure of 110/75 mm Hg\n* BMI of 19 kg/m^2\n* Examination findings:\n  - Track marks on both cubital fossae\n  - White patches on the palate (likely thrush)\n  - Red papules measuring 1 to 2 cm on the face and trunk\n* CD4+T-lymphocyte count of 98/mm^3 (indicative of advanced HIV disease)\n\n### Biopsy Findings\n\nThe biopsy of a skin lesion reveals:\n\n* Vascular proliferation\n* Small black bacteria on Warthin-Starry stain\n\n### Diagnosis\n\nBased on the clinical presentation, biopsy findings, and patient's history, the diagnosis is Bacillary Angiomatosis (BA).\n\n### Pathophysiology\n\nBacillary Angiomatosis is caused by Bartonella henselae and Bartonella quintana. These bacteria are transmitted by cat scratches or through contact with cat feces.\n\n### Treatment\n\nThe most appropriate pharmacotherapy for Bacillary Angiomatosis is:\n\n### Recommended Treatment\n\n* **Doxycyline**: This is the preferred treatment for Bacillary Angiomatosis. Doxycycline has been shown to be effective in treating BA and is often used as the first-line treatment.\n\n### Alternative Treatment Options\n\n* **Erythromycin**: This is an alternative treatment option for patients who are allergic to doxycycline or have other contraindications.\n* **Azithromycin**: This is another alternative treatment option for patients who are allergic to doxycycline or have other contraindications.\n\n### Important Consideration\n\n* **Dapsone**: This should not be used as the treatment for Bacillary Angiomatosis. Dapsone is not effective against BA and may even worsen the condition.\n\n### Summary\n\nThe most appropriate pharmacotherapy for this patient with Bacillary Angiomatosis is doxycycline. Erythromycin and azithromycin are alternative treatment options, while dapsone should not be used due to its lack of efficacy.",
    "true_answer": "The most appropriate pharmacotherapy for this patient is erythromycin."
  },
  {
    "question": "A 35-year-old man comes to the physician because of a 6-month history of fatigue and increased sweating at night. He says that he feels 'constantly tired' and needs more rest than usual although he sleeps well. In the morning, his sheets are often wet and his skin is clammy. He has not had any sore throat, runny nose, or cough recently. He has not traveled anywhere. Over the past 4 months, he has had a 6.8-kg (15-lb) weight loss, despite having a normal appetite. He does not drink or urinate more than usual. He is 181 cm (5 ft 11 in) tall and weighs 72 kg (159 lb); BMI is 22 kg/m2. His temperature is 37.9\u00b0C (100.2\u00b0F), pulse is 65/min, and blood pressure is 120/70 mm Hg. Physical examination shows no abnormalities. An HIV screening test and confirmatory test are both positive. The CD4 count is 600 cells/\u03bcl and the viral load is 104 copies/mL. Treatment with lamivudine, zidovudine, and indinavir is begun. The patient is at greatest risk for what adverse effects?",
    "answer": "### Adverse Effects of Antiretroviral Therapy\n\nThe patient is receiving a combination of antiretroviral medications, including lamivudine, zidovudine, and indinavir. These medications are used to treat HIV infection, but they can cause various adverse effects.\n\n### Protease Inhibitors and Adverse Effects\n\nIndinavir is a protease inhibitor, a class of antiretroviral medications that can cause several adverse effects.\n\n#### Nephrolithiasis\n\n- Protease inhibitors, including indinavir, can increase the risk of kidney stones (nephrolithiasis).\n- This is due to the medication's effect on the kidneys, which can lead to the formation of stones.\n\n#### Lipodystrophy\n\n- Protease inhibitors can also cause lipodystrophy, a condition characterized by abnormal fat distribution in the body.\n- This can lead to changes in body shape, such as buffalo hump, facial wasting, and abdominal fat accumulation.\n\n#### Hyperglycemia\n\n- Protease inhibitors can cause hyperglycemia, or high blood sugar levels, which can increase the risk of developing diabetes.\n- This is a significant concern, as it can lead to long-term complications if left untreated.\n\n#### Dyslipidemia\n\n- Protease inhibitors can also cause dyslipidemia, or abnormal levels of lipids in the blood.\n- This can increase the risk of cardiovascular disease and other complications.\n\n### Other Medications and Adverse Effects\n\n- Lamivudine and zidovudine are nucleoside reverse transcriptase inhibitors (NRTIs), which can cause different adverse effects, such as:\n  - Lactic acidosis: a potentially life-threatening condition caused by the accumulation of lactic acid in the blood.\n  - Myopathy: muscle weakness or wasting, which can lead to difficulties with daily activities.\n  - Anemia: a decrease in red blood cells, which can lead to fatigue, weakness, and shortness of breath.\n\n### Conclusion\n\nGiven the patient's treatment regimen, he is at greatest risk for nephrolithiasis (kidney stones) due to the use of indinavir, a protease inhibitor.",
    "true_answer": "The patient is at greatest risk for developing urolithiasis as an adverse effect."
  },
  {
    "question": "A 52-year-old man is brought to the emergency department because of headaches, vertigo, and changes to his personality for the past few weeks. He was diagnosed with HIV 14 years ago and was started on antiretroviral therapy at that time. Medical records from one month ago indicate that he followed his medication schedule inconsistently. Since then, he has been regularly taking his antiretroviral medications and trimethoprim-sulfamethoxazole. His vital signs are within normal limits. Neurological examination shows ataxia and apathy. Mini-Mental State Examination score is 15/30. Laboratory studies show: Hemoglobin 12.5 g/dL Leukocyte count 8400/mm3 Segmented neutrophils 80% Eosinophils 1% Lymphocytes 17% Monocytes 2% CD4+ T-lymphocytes 90/\u03bcL Platelet count 328,000/mm3 An MRI of the brain with contrast shows a solitary ring-enhancing lesion involving the corpus callosum and measuring 4.5 cm in diameter. A lumbar puncture with subsequent cerebrospinal fluid analysis shows slight pleocytosis, and PCR is positive for Epstein-Barr virus DNA. What is the most likely diagnosis?",
    "answer": "### Patient Presentation\nA 52-year-old man presents to the emergency department with headaches, vertigo, and changes to his personality over the past few weeks. He has a history of HIV, diagnosed 14 years ago, and was initially started on antiretroviral therapy (ART). However, he has been inconsistent with his medication schedule, which may have led to immune system suppression.\n\n### Key Findings\n- **HIV Status and Medication Adherence**: The patient has a history of HIV and has been taking antiretroviral therapy inconsistently.\n- **Symptoms**: Headaches, vertigo, and changes in personality.\n- **Neurological Examination**: Ataxia and apathy.\n- **Mini-Mental State Examination Score**: 15/30, indicating significant cognitive impairment.\n- **Laboratory Studies**: CD4+ T-lymphocytes count is 90/\u03bcL, indicating immunosuppression.\n- **MRI Findings**: A solitary ring-enhancing lesion involving the corpus callosum, measuring 4.5 cm in diameter.\n- **Cerebrospinal Fluid Analysis**: Slight pleocytosis and PCR positive for Epstein-Barr virus DNA.\n\n### Diagnosis\nBased on the patient's symptoms, laboratory findings, and imaging results, the most likely diagnosis is **Primary Central Nervous System Lymphoma (PCNSL)**.\n\n### Explanation\nPCNSL is a type of non-Hodgkin lymphoma that occurs within the central nervous system (CNS). In immunosuppressed individuals, such as those with HIV/AIDS, PCNSL is often caused by Epstein-Barr virus (EBV) infection. The presence of EBV DNA in the cerebrospinal fluid and the patient's immunosuppressed state support this diagnosis.\n\n### Key Features of PCNSL\n- **Ring-enhancing lesion**: PCNSL typically presents as a solitary ring-enhancing lesion on MRI.\n- **Immunosuppression**: PCNSL is more common in individuals with weakened immune systems, such as those with HIV/AIDS.\n- **EBV infection**: EBV is a common cause of PCNSL in immunosuppressed individuals.\n\n### Conclusion\nThe combination of the patient's immunosuppressed state, the presence of EBV DNA in the cerebrospinal fluid, and the characteristic ring-enhancing lesion on MRI strongly supports the diagnosis of Primary Central Nervous System Lymphoma (PCNSL).",
    "true_answer": "The most likely diagnosis is CNS lymphoma."
  },
  {
    "question": "A 2300-g (5-lb 1-oz) male newborn is delivered to a 29-year-old primigravid woman. The mother has HIV and received triple antiretroviral therapy during pregnancy. Her HIV viral load was 678 copies/mL 1 week prior to delivery. Labor was uncomplicated. Apgar scores are 7 and 8 at 1 and 5 minutes respectively. Physical examination of the newborn shows no abnormalities. What is the most appropriate next step in management of this infant?",
    "answer": "The most appropriate next step in the management of this infant would be to administer antiretroviral prophylaxis to prevent mother-to-child transmission of HIV. \n\nHere's a step-by-step explanation:\n\n1. **Initial Assessment**: The infant is born to a mother with HIV, indicating a high risk of mother-to-child transmission. However, the mother received antiretroviral therapy during pregnancy, which significantly reduces the risk of transmission.\n\n2. **Viral Load**: The mother's viral load was 678 copies/mL 1 week prior to delivery, which is considered relatively low. This suggests that the antiretroviral therapy was effective in controlling the virus.\n\n3. **Apgar Scores**: The Apgar scores of 7 and 8 at 1 and 5 minutes, respectively, indicate that the infant is in good condition after birth.\n\n4. **Physical Examination**: The physical examination shows no abnormalities, which is reassuring.\n\n5. **Prophylaxis**: Despite the mother's low viral load and the infant's good condition, antiretroviral prophylaxis should still be administered to the infant. This is because even with low viral loads, there is still a risk of transmission.\n\nThe recommended antiretroviral prophylaxis for the infant would typically include zidovudine (AZT) and possibly other medications, depending on the specific guidelines and the mother's treatment regimen. The dosage and duration of the prophylaxis would be determined by the healthcare provider based on the infant's weight and the mother's viral load.\n\nTherefore, the most appropriate next step in the management of this infant is to administer antiretroviral prophylaxis to prevent mother-to-child transmission of HIV.",
    "true_answer": "The next best step in management for this infant is to administer zidovudine."
  }
]